| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/27/2000 | CA2346798A1 Novel neuropilin/growth factor binding and uses thereof |
| 04/26/2000 | EP0995751A2 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 04/26/2000 | EP0995750A1 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 04/26/2000 | EP0995443A1 Composition for treating burn wounds, skin abrasions and herpes |
| 04/26/2000 | EP0995433A1 Retinol stabilized cleansing compositions |
| 04/26/2000 | EP0994870A1 Novel aryloxy substituted pyrimidine imidazole compounds |
| 04/26/2000 | EP0994853A2 Compounds and methods for the inhibition of the expression of vcam-1 |
| 04/26/2000 | EP0994716A1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |
| 04/26/2000 | EP0738269B1 Piperidine derivatives with paf antagonist activity |
| 04/26/2000 | CN1251530A Use of substaces having oxytocin activity for preparation of medicaments for wound healing |
| 04/26/2000 | CN1251529A Use of bacterial cell wall extracts for treating, preventing or removing protozoa or parasitism diseases |
| 04/26/2000 | CN1251309A Method for preparing medicinal absinthium extracted liquor and electro-moxibustion apparatus using said extracted liquor |
| 04/26/2000 | CN1051762C Vitamin D3 analogs, preparation method and use, and medicinal composition containing same |
| 04/26/2000 | CN1051758C Anti-androgenic cyclo and bicycle alkenes |
| 04/26/2000 | CN1051704C Composition containing retionic acids and tocopherol |
| 04/25/2000 | US6054599 Phytosphingosine-based ceramide I analogs |
| 04/25/2000 | US6054470 Src family SH2 domain inhibitors |
| 04/25/2000 | US6054449 Photodynamic therapy |
| 04/25/2000 | US6054137 Promoting epidermal renewal with phloroglucinol |
| 04/23/2000 | CA2287562A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 04/20/2000 | WO2000022143A2 Protein kinase homologs |
| 04/20/2000 | WO2000021986A2 Matrix-remodeling genes |
| 04/20/2000 | WO2000021964A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and anfiinflammatory activity |
| 04/20/2000 | WO2000021963A1 Il-8 receptor antagonists |
| 04/20/2000 | WO2000021961A1 Imidazo-isoquinoline compounds, their compositions and uses |
| 04/20/2000 | WO2000021959A1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 04/20/2000 | WO2000021927A2 Pyrrole-2,5-diones as gsk-3 inhibitors |
| 04/20/2000 | WO2000021920A1 Diaminopropionic acid derivatives |
| 04/20/2000 | WO2000021557A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | WO2000021545A1 Substances from the 'milk' of the leaf of the fig tree for the treatment warts |
| 04/20/2000 | WO2000021530A1 Peripherally acting anti-pruritic opiates |
| 04/20/2000 | WO2000021490A1 Use of nanoscale sterols and sterol esters |
| 04/20/2000 | WO2000021486A2 Prevention of uv-induced functional vitamin a deficiency through use of topically applied retinoid |
| 04/20/2000 | WO2000005245A3 Inhibitors of urokinase and blood vessel formation |
| 04/20/2000 | WO2000003749A3 Method for regulating hair growth |
| 04/20/2000 | WO2000003689A3 Skin and tissue care and/or treatment agent |
| 04/20/2000 | WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors |
| 04/20/2000 | WO1999048868A9 Heterocyclic classes of compounds for the modulating tyrosine protein kinase |
| 04/20/2000 | DE19848130A1 Cholesteric liquid crystalline polymer especially in pigment form, useful as UV filters in cosmetic and pharmaceutical preparations |
| 04/20/2000 | DE19845372A1 Verwendung von Katecholderivaten als Proteinaseninhibitoren Using catechol as proteinase inhibitors |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |
| 04/20/2000 | CA2346542A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and antiinflammatory activity |
| 04/20/2000 | CA2346464A1 Peripherally acting anti-pruritic opiates |
| 04/20/2000 | CA2346414A1 Imidazo-isoquinoline compounds, their compositions and uses |
| 04/20/2000 | CA2346006A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | CA2344696A1 Prevention of uv-induced functional vitamin a deficiency through use of topically applied retinoid |
| 04/20/2000 | CA2314004A1 Matrix-remodeling genes |
| 04/19/2000 | EP0993825A2 Urea containing composition and its cosmetic and dermatologic use |
| 04/19/2000 | EP0993822A1 Ceramide production-accelerating agent |
| 04/19/2000 | EP0993449A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
| 04/19/2000 | EP0993439A1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 04/19/2000 | EP0993437A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 04/19/2000 | EP0789711B1 Identification of the p21-waf1 -pcna interaction site and therapeutic applications thereof |
| 04/19/2000 | EP0769950A4 Method and compound for the treatment of hair loss |
| 04/19/2000 | EP0738262B1 Novel heterocyclic compounds |
| 04/19/2000 | EP0668769B1 Synthetic compositions related to oak bark extrakt, and method of using same |
| 04/19/2000 | CN1251038A IL-8 receptor antagonists |
| 04/19/2000 | CN1250660A Liquid medicine for treating wound and pain |
| 04/19/2000 | CN1051460C Method for treatment of leukoderma and its preparing method |
| 04/19/2000 | CN1051453C Compositions of clindamycin and benzoyl peroxide for acne treatment |
| 04/18/2000 | US6051243 Polyaromatic amide compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 04/13/2000 | WO2000020645A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF TUMOR NECROSIS FACTOR-α (TNF-α) EXPRESSION |
| 04/13/2000 | WO2000020447A2 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 04/13/2000 | WO2000020434A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | WO2000020402A1 Chemical compounds |
| 04/13/2000 | WO2000020398A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | WO2000020397A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | WO2000020389A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | WO2000020388A1 Indolin derivatives as sun protection agents |
| 04/13/2000 | WO2000020371A1 Prostaglandin receptor ligands |
| 04/13/2000 | WO2000020370A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 04/13/2000 | WO2000020013A1 Reduction of oxidative stress factors |
| 04/13/2000 | WO2000020003A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | WO2000019999A1 Fulvic acid and its use in the treatment of various conditions |
| 04/13/2000 | WO2000019989A2 Use of catechol derivatives as proteinase inhibitors |
| 04/13/2000 | WO2000019974A1 Method for prevention and/or cosmetic treatment of skin striae and use in dermatology |
| 04/13/2000 | WO2000019969A1 Hair tonic |
| 04/13/2000 | WO1999062451A9 Topical transdermal treatments |
| 04/13/2000 | WO1999053897A3 Topical formulation comprising poloxamers and further microbicides, and an applicator |
| 04/13/2000 | CA2346445A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | CA2346443A1 Prostaglandin receptor ligands |
| 04/13/2000 | CA2346037A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | CA2346034A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 04/13/2000 | CA2346019A1 Use of catechol derivatives as proteinase inhibitors |
| 04/13/2000 | CA2345881A1 Bone marrow-derived serum proteins |
| 04/13/2000 | CA2345377A1 Novel secreted proteins and polynucleotides encoding them |
| 04/13/2000 | CA2345133A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | CA2345110A1 Reduction of oxidative stress factors |
| 04/13/2000 | CA2344807A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | CA2344616A1 Antisense oligonucleotide modulation of tumor necrosis factor-.alpha. (tnf-.alpha.) expression |
| 04/13/2000 | CA2344266A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | CA2341374A1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 04/13/2000 | CA2285812A1 Retinol stabilized cleansing compositions |
| 04/12/2000 | EP0992493A1 Substituted benzoylpiperidine derivatives and their use as Neurokinin antagonists |
| 04/12/2000 | EP0991660A1 Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/12/2000 | EP0991653A1 Novel compounds |
| 04/12/2000 | EP0991636A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 04/12/2000 | EP0991628A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56?lck TYROSINE KINASES |
| 04/12/2000 | EP0991423A1 Topical treatment of psoriasis using neutralizing antibodies to il-8 |
| 04/12/2000 | EP0991422A1 Modulating epithelial-mesenchymal interactions |